GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (NYSE:NVO) » Definitions » Balance Sheet Cash And Cash Equivalents
中文

Novo Nordisk A/S (Novo Nordisk A/S) Balance Sheet Cash And Cash Equivalents


View and export this data going back to 1981. Start your Free Trial

Novo Nordisk A/S Balance Sheet Cash And Cash Equivalents Definition

Please go to this page to see Cash And Cash Equivalents for non-financial companies.


Novo Nordisk A/S (Novo Nordisk A/S) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novo Nordisk A/S (NYSE:NVO) » Definitions » Balance Sheet Cash And Cash Equivalents
Address
Novo Alle 1, Bagsvaerd, DNK, DK-2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.